Image Frame Investment (Hk) Limited investment portfolio

bit.bio builds a synthetic‑biology platform that programmatically converts human iPSCs into any desired cell type, delivering highly characterised, scalable cells for research, drug discovery and cell‑therapy development. Its products serve pharmaceutical companies, biotech firms and academic laboratories that need consistent human cell models.

Broken String Biosciences develops the INDUCE‑seq® platform, a novel sequencing tool that provides genome‑wide DNA break analysis to assess and improve the safety and efficacy of gene‑editing and cell‑therapy programs, targeting biotech and pharmaceutical developers as well as regulatory agencies.